Ming Zhou1, Thomas P Conrads, Timothy D Veenstra
1SAIC-Frederick, Inc., National Cancer Institute at Frederick, P.O. Box B, Bldg. 469, Rm. 160, Frederick, MD 21702, USA.
Mass spectrometry (MS) technologies generate vast proteomic data for comparative biofluid analysis. This advancement is key for identifying disease biomarkers and developing future diagnostic tools.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: